Pyridine nucleotides
- (8)
- (1)
- (2)
- (1)
- (2)
- (3)
- (1)
- (7)
- (1)
- (1)
- (24)
- (1)
- (1)
- (2)
- (2)
- (1)
- (7)
- (5)
- (3)
- (3)
- (3)
- (1)
- (11)
- (1)
- (5)
Filtered Search Results
beta-Nicotinamide adenine dinucleotide, 97%
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
beta-Nicotinamide adenine dinucleotide hydrate, 98+%
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide Adenine Dinucleotide, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide adenine dinucleotide phosphate, Cell Culture Reagent, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide Adenine Dinucleotide, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide adenine dinucleotide, oxidized Form, free acid, >98%, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
b-Nicotinamide Adenine Dinucleotide, 95%, Spectrum™ Chemical
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N IUPAC Name: 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| CAS | 53-84-9 |
|---|---|
| Molecular Weight (g/mol) | 663.43 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| IUPAC Name | 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide Adenine Dinucleotide, Oxidized, Free Acid, 99%, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
beta-Nicotinamide Adenine Dinucleotide Hydrate, oxidized form 95.0+%, TCI America™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
beta-Nicotinamide Adenine Dinucleotide Phosphate 83.0+%, TCI America™
CAS: 53-59-8 Molecular Formula: C21H30N7O18P3 Molecular Weight (g/mol): 761.423 MDL Number: MFCD00067537 InChI Key: ZKJOXOJMGXFSPF-QYZPTAICSA-N Synonym: Coenzyme II, beta-NADP, TPN, beta-Triphosphopyridine Nucleotide PubChem CID: 131675342 IUPAC Name: [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate;hydrate SMILES: C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)([O-])OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)OP(=O)(O)O)O)O)O)C(=O)N.O
| PubChem CID | 131675342 |
|---|---|
| CAS | 53-59-8 |
| Molecular Weight (g/mol) | 761.423 |
| MDL Number | MFCD00067537 |
| SMILES | C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)([O-])OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)OP(=O)(O)O)O)O)O)C(=O)N.O |
| Synonym | Coenzyme II, beta-NADP, TPN, beta-Triphosphopyridine Nucleotide |
| IUPAC Name | [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate;hydrate |
| InChI Key | ZKJOXOJMGXFSPF-QYZPTAICSA-N |
| Molecular Formula | C21H30N7O18P3 |
Sigma Aldrich Fine Chemicals Biosciences beta-Nicotinamide adenine dinucleotide hydrate >=98%, BioUltra, from yeast | 53-84-9 | MFCD00036253 | 250MG
beta-Nicotinamide adenine dinucleotide hydrate >=98%, BioUltra, from yeast | Purity: >=98% | 53-84-9 | MFCD00036253 | 250MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences BETA-Nicotinamide mononucleotide, 1094-61-7, MFCD00038748, 25 mg
Empirical Formula (Hill Notation): C11H15N2O8P, Molecular Weight: 334.22, ≥95% (HPLC), storage temp: −20°C, Synonym: β-NMN, β-Nicotinamide ribose monophosphate, NMN, Nicotinamide ribotide, Nicotinamide-1-ium-1-β-D-ribofuranoside 5′-phosphate.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC Nicotinamide(Synonyms: Nicotinic acid amide, Vitamin B3 amide, Niacinamide, Pyridine-3-carboxamide, 3-Pyridinecarboxamide), 1g, CAS: 98-92-0.
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Nicotinamide (CAS 98-92-0) is a small-molecule inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) an enzyme critical in DNA repair pathways Under pathological conditions such as ischemia or trauma PARP-1 hyperactivation depletes cellular NAD triggering neuronal cell death In vitro studies indicate that transporter-mediated uptake of nicotinamide confers protection against PARP-1-induced astrocyte injury In vivo studies in diabetic rat models demonstrate that nicotinamide administration normalizes hepatic antioxidant enzymes reducing oxidative stress Clinical trials have shown dose-dependent upregulation of frataxin expression following sustained nicotinamide treatment suggesting therapeutic potential in disorders like Friedreich s ataxia
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences beta-Nicotinamide mononucleotide >=95% (HPLC) | 1094-61-7 | MFCD00038748 | 500MG
beta-Nicotinamide mononucleotide >=95% (HPLC) | Purity: >=95% (HPLC); >=95% (spectrophotometric assay) | Mol Wt: 334.22 | 1094-61-7 | MFCD00038748 | 500MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More